Prescription omega-3 fatty acids
What the study found
The American Heart Association science advisory concludes that prescription omega-3 fatty acids at 4 g/day are effective at lowering elevated triglycerides. In hypertriglyceridemia, reductions of roughly 20-30% have been reported, with greater reductions possible when baseline triglycerides are very high.
Limitations
- This evidence applies to prescription omega-3 formulations and pharmacologic doses.
- Do not translate the effect size to ordinary fish servings or over-the-counter fish-oil supplements.
- Effects on LDL cholesterol can differ by formulation and baseline triglyceride level.
- Do not provide medication dosing instructions to users.
- Do not imply omega-3 therapy replaces clinician-directed lipid management.
- Do not infer cardiovascular-event reduction solely from triglyceride lowering unless a specific outcome trial supports that claim.
What this says about long-term health
Triglyceride lowering is established. Broader cardiovascular benefit must be tied to the specific formulation and outcome evidence rather than generalized to all omega-3 products.